top of page
AdobeStock_170980846_edited.jpg

news & insights

Market Access Insights

As market access consultants in Belgium, based in Ghent and working across the Benelux, Axes Health helps international pharma and biotech companies navigate that landscape from early strategy through reimbursement and beyond.

 

These insights explains how the Belgian market access system actually works, what changed in 2026, and how the right approach turns a complex process into a predictable pathway to patients.

Under the National Institute for Health and Disability Insurance (NIHDI) Roadmap on Access, the pricing and reimbursement process is being reformed step by step, with the aim of giving patients faster access to affordable and innovative medicines.

Royal Decree “Pot-Pourri” 2026 Explained

Under the National Institute for Health and Disability Insurance (NIHDI) Roadmap on Access, the pricing and reimbursement process is being reformed step by step, with the aim of giving patients faster access to affordable and innovative medicines.

Start Now
Rare Diseases Forum 2026 - because breakthroughs only matter if they reach the patients who need them

Rare Diseases Forum 2026: Innovation & Access

Rare Diseases Forum 2026 - because breakthroughs only matter if they reach the patients who need them

Start Now
Early access programmes make it possible to start an innovative treatment earlier in case of a clear medical need.

Innovation Access Programs

Early access programmes make it possible to start an innovative treatment earlier in case of a clear medical need.

Start Now
https://www.linkedin.com/feed/update/urn:li:activity:7444705308943405056/

Fast Access Belgium 2026 Explained

https://www.linkedin.com/feed/update/urn:li:activity:7444705308943405056/

Start Now
Modernisation of Reimbursement Procedures in Belgium

Belgium Reimbursement Reform

Modernisation of Reimbursement Procedures in Belgium

Start Now
Joint Clinical Assessment: bridging European assessment with national patient access solutions

JCA Solutions for European HTA

Joint Clinical Assessment: bridging European assessment with national patient access solutions

Start Now
Under the National Institute for Health and Disability Insurance (NIHDI) Roadmap on Access, the pricing and reimbursement process is being reformed step by step, with the aim of giving patients faster access to affordable and innovative medicines.

Royal Decree “Pot-Pourri” 2026 Explained

Under the National Institute for Health and Disability Insurance (NIHDI) Roadmap on Access, the pricing and reimbursement process is being reformed step by step, with the aim of giving patients faster access to affordable and innovative medicines.

Read more
Rare Diseases Forum 2026 - because breakthroughs only matter if they reach the patients who need them

Rare Diseases Forum 2026: Innovation & Access

Rare Diseases Forum 2026 - because breakthroughs only matter if they reach the patients who need them

Read more
Early access programmes make it possible to start an innovative treatment earlier in case of a clear medical need.

Innovation Access Programs

Early access programmes make it possible to start an innovative treatment earlier in case of a clear medical need.

Read more
https://www.linkedin.com/feed/update/urn:li:activity:7444705308943405056/

Fast Access Belgium 2026 Explained

https://www.linkedin.com/feed/update/urn:li:activity:7444705308943405056/

Read more
Modernisation of Reimbursement Procedures in Belgium

Belgium Reimbursement Reform

Modernisation of Reimbursement Procedures in Belgium

Read more
Joint Clinical Assessment: bridging European assessment with national patient access solutions

JCA Solutions for European HTA

Joint Clinical Assessment: bridging European assessment with national patient access solutions

Read more
bottom of page